ArticleBlood advances2021

Cost-effectiveness analysis of oral azacitidine maintenance therapy in acute myeloid leukemia.

Jan Philipp Bewersdorf et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.